alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NORWEST BANK MINNESOTA, N.A.
11000 Broken Land Parkway, 2nd Floor
Columbia, Maryland 21044-3562
Attn: Vice President Master Servicing Department

RE:     Officer's Certificate

Dear Master Servicer:

The undersigned Officer certifies the following for the 1995 fiscal year:

(A) I have reviewed the activities and  performances  of the Servicer during the
preceding  fiscal  year  under  the  terms  of the  Servicing  Agreement,  Trust
Agreement, Pooling and Servicing Agreement and/or Servicer Guide and to the best
of my knowledge, the Servicer has fulfilled all of its duties,  responsibilities
or obligations under these Agreements throughout such year, or if there has been
a  default  or   failure  of  the   Servicer   to  perform   any  such   duties,
responsibilities  or  obligations,  a description of each default or failure and
the nature and status thereof has been reported to Norwest Bank Minnesota, N.A.;

(B) I have  confirmed  that the Servicer is currently an approved  FNMA or FHLMC
Servicer in good standing;

(C) I have  confirmed  that  the  Fidelity  Bond,  the  Errors  and  Omissions
Insurance  Policy and any other bonds  required under the terms of the Servicing
Agreement,  Trust  Agreement,  Pooling and Servicing  Agreement  and/or Servicer
Guide are in full force and effect;

(D) All premiums for each Hazard  Insurance  Policy,  Flood Insurance Policy (if
applicable) and Primary Mortgage Insurance Policy (if applicable),  with respect
to each Mortgaged Property,  have been paid and that all such insurance policies
are in full force and effect;

(E) All real  estate  taxes,  governmental  assessments  and any other  expenses
accrued and due, that if not paid could result in a lien or  encumbrance  on any
Mortgaged  Property,  have been paid,  or if any such costs or expenses have not
been paid with respect to any Mortgaged Property, the reason for the non-payment
has been reported to Ryland Mortgage Company;

(F) All   Custodial  Accounts have been reconciled and are properly funded;  and

(G) All annual reports of  Foreclosure  and  Abandonment  of Mortgaged  Property
required per section 6050J and 6050P of the Internal Revenue Code, respectively,
have been prepared and filed.



Certified by:
/s/Scott Dalgleish
Officer

AVP
Title

7/22/96
Date
<TABLE>

(in 000's, except per share amounts)

<S>                                  <C>        <C>          <C>         <C>
                                     Three Months Ended       Six Months Ended    
                                     July 4,    June 28,     July 4,     June 28,
                                      1998        1997        1998         1997   

Weighted average shares outstanding   47,821      48,252      47,454      48,155

Effect of dilutive securities          1,719       1,235       1,639       1,425  

Shares for diluted EPS                49,540      49,487      49,093      49,580
                                    =========   =========   =========   =========


Income from continuing operations   $ 25,830    $ 18,107    $ 43,447    $ 31,761  
                                    =========   =========   =========   =========


Per share amounts:

  Basic                             $   0.54    $   0.38    $   0.92    $   0.66
                                    =========   =========   =========   =========


  Diluted                           $   0.52    $   0.37    $   0.88    $   0.64
                                    =========   =========   =========   =========
</TABLE>
AFS-12-333-E June 29, 2012

Mr. Omer ErSelcuk

President/Chief Executive Officer Seaborne Virgin Islands, Inc., d.b.a. Seaborne Airlines 1210 Watergut Street Christiansted, VI 00820

Dear Mr. ErSelcuk:

This is in response to your April 19, 2012, letter (public docket No. FAA-2010-0947) petitioning the Federal Aviation Administration (FAA) on behalf of Seaborne Virgin Islands, Inc., d.b.a. Seaborne Airlines (Seaborne Airlines) for an extension of Exemption No. 10179, as amended, to June 30, 2013. That exemption from § 121.173(b)(2) and Appendix K, paragraph 5a, of part 121 of Title 14, Code of Federal Regulations allows Seaborne Airlines to continue to operate DHC-6-300 wheel-equipped airplanes after the December 20, 2010, effective date without meeting certain aircraft performance requirements.

On September 8, 2011, The FAA published Type Certificate Data Sheet (TCDS)

No. A9EA , Revision No. 14, for the Model DHC-6-300 (Normal Category) aircraft. This TCDS Revision 14 includes the commuter category performance requirements as specified by part 121, Appendix K, paragraph (5)(b). Therefore the wheel-equipped DHC-6-300 aircraft for which this exemption applied are now able to comply with the requirements of part 121, Appendix K. These aircraft must now comply with part 121, Appendix K, paragraph 6. Operation. Further extension of Exemption No. 10179 is no longer required.

For Model DHC-6-300 airplanes intended for operations in accordance with the performance limitations of § 121.189 through 121.197, the Airplane Flight Manual Supplement #37 – Supplemental Performance Data, is to be inserted in the Airplane Flight Manual, document PSM 1-63-1A and used to comply with part 121, Appendix K.2 Therefore, the FAA will take no further action on your petition and Docket No. FAA-2010- 0947 is being closed.

Sincerely,

/S/

Leslie Smith Acting Director, Flight Standards

Service

Enclosure
§ 1150.9 Domestic manufacturer or importer assessment. Each quarter, FDA will calculate the assessment owed by each domestic manufacturer or importer for that quarter. ( a ) *Calculation.* ( 1 ) For each class of tobacco products except cigars, FDA will calculate the percentage share for each domestic manufacturer and importer by dividing the Federal excise taxes that it paid for the class for the prior quarter by the total excise taxes that all domestic manufacturers and importers paid for the class for that same quarter.
( 2 ) For the cigar class, FDA will calculate the percentage share for each domestic manufacturer and importer by dividing the Federal excise taxes that it paid for the class for the prior fiscal year by the total excise taxes that all domestic manufacturers and importers paid for the class for the prior fiscal year.
( 3 ) If the percentage share calculated for a domestic manufacturer or importer in this section, as applicable, is less than 0.0001 percent, the share is excluded from the assessment for that class of tobacco products.
( 4 ) Within each class of tobacco products, the assessment owed by a domestic manufacturer or importer for the quarter is the yearly class allocation, determined as described in § 1150.7, divided by four, multiplied by the domestic manufacturer's or importer's percentage share, truncated to the fourth decimal place, for that class of tobacco products.
( b ) *Adjustments.* Annually, FDA will make any necessary adjustments to individual domestic manufacturer or importer assessments if needed to account for any corrections (for example, to include domestic manufacturers or importers that were not included in a relevant assessment calculation).
[79 FR 39310, July 10, 2014, as amended at 81 FR 28716, May 10, 2016]
http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201510&RIN=2040-AF58&operation=OPERATION_PRINT_RULE[11/24/2015 7:43:08 AM]

RIN Data

EPA/WATER RIN: 2040-AF58 Publication ID: Fall 2015

Title: ?Section 610 Review of National Primary Drinking Water Regulations: Ground Water Rule(Section 610 Review)

Abstract:

EPA published the Ground Water Rule (GWR) in the Federal Register on November 8, 2006. The purpose of the rule is to provide for

increased protection against microbial pathogens in public water systems that use ground water sources. EPA is particularly concerned about

ground water systems that are susceptible to fecal contamination since disease-causing pathogens may be found in fecal contamination. The

GWR applies to public water systems that serve ground water. The rule also applies to any system that mixes surface and ground water if the

ground water is added directly to the distribution system and provided to consumers without treatment. This new entry in the regulatory

agenda announces that EPA will review this action in the fall of 2015 pursuant to section 610 of the Regulatory Flexibility Act (5 U.S.C. 610).

As part of this review, EPA solicits comments for consideration on the following factors: (1) The continued need for the rule; (2) the nature of

complaints or comments received concerning the rule; (3) the complexity of the rule; (4) the extent to which the rule overlaps, duplicates, or

conflicts with other Federal, State, or local government rules; and (5) the degree to which the technology, economic conditions or other factors

have changed in the area affected by the rule. Submit your comments, identified by Docket ID No. EPA-HQ-OW-2015-0541 to the Federal

eRulemaking Portal: http://www.regulations.gov. Follow the online instructions for submitting comments.

Agency: Environmental Protection Agency(EPA) Priority: Info./Admin./Other

RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Prerule Stage

Major: No Unfunded Mandates: No

RFA Section 610 Review: Section 610 Review

CFR Citation: None (To search for a specific CFR, visit the Code of Federal Regulations.)

Legal Authority: 5 U.S.C. 610 

Legal Deadline: None

Timetable:

Action Date FR Cite

Final Rule 11/08/2006 71 FR 65573 

Begin Review 11/00/2015

End Review 04/00/2016

Additional Information: Docket #:EPA-HQ-OW-2015-0541

Regulatory Flexibility Analysis Required: No Government Levels Affected: None

Small Entities Affected: No Federalism: No

Included in the Regulatory Plan: No

RIN Information URL: http://www2.epa.gov/reg-flex/section-610-

reviews

RIN Data Printed in the FR: Yes

Agency Contact:

Crystal Rodgers-Jenkins 

Environmental Protection Agency 

Water 

4607M, 

Washington, DC 20460 

Phone:202 564-5275 

Fax:202 564-3767 

Email: rodgers-jenkins.crystal@epa.gov 

Stephanie Flaharty 

Environmental Protection Agency 

Water 

4601M, 

Washington, DC 20460 

Phone:202 564-5072 

Email: flaharty.stephanie@epa.gov 
http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201510&RIN=2040-AF58&operation=OPERATION_PRINT_RULE[11/24/2015 7:43:08 AM]
---

---

Exhibit 14.3

CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by
reference in the Registration Statements of NUR Macroprinters Ltd. on Form S-8 (File Nos.
333-102288 and 333-92491) and Form F-3 (File Nos. 333-115826, 333-114428, 333-47842 and
333-92493) of our report dated January 26, 2006 relating to the financial statements of
NUR Japan Limited for the year ended December, 31, 2003 with respect to the Consolidated
Financial Statements of NUR Macroprinters Ltd., included in its Annual Report on Form 20-F
for the year ended December 31, 2005.

|/s/ Grant Thornton Tokyo
ASG
Certified Public
Accountants |  | 
|----------------------------------------------------------------------- |  | 

July 12, 2006



---

---
Editorial Note on Part 172
Editorial Note: Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 172.852 Glyceryl-lacto esters of fatty acids. Glyceryl-lacto esters of fatty acids (the lactic acid esters of mono- and diglycerides) may be safely used in food in accordance with the following prescribed conditions: ( a ) They are manufactured from glycerin, lactic acid, and fatty acids conforming with § 172.860 and/or oleic acid derived from tall oil fatty acids conforming with § 172.862 and/or edible fats and oils.
( b ) They are used in amounts not in excess of those reasonably required to accomplish their intended physical or technical effect as emulsifiers and plasticizers in food.
#### § 516.2 Purpose.

This part establishes standards and procedures for implementing section 573 of the act, including designation of minor use or minor species new animal drugs and associated exclusive marketing rights.
### Ground-water resources of the Lambayeque Valley, Department of Lambayeque, northern Peru

By: Stuart L. SchoffM. Juan Luis Sayan

                            https://doi.org/10.3133/wsp1663F

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plates:                               - **Plate 1**                            (pdf)
  - **Plate 2**                            (pdf)
  - **Plate 3**                            (pdf) 
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
<PAGE>   1

                                                                   EXHIBIT 23.2



                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


The Board of Directors and Stockholders of
Airways Corporation and Subsidiary:

We consent to incorporation by reference in the registration statement (No. 33 -
98566) on Form S-8 of Airways Corporation and subsidiary of our report dated
June 6, 1997, relating to the consolidated balance sheets of Airways Corporation
and subsidiary as of March 31, 1997 and 1996 and the related consolidated
statements of operations, changes in stockholders' equity and group equity and
cash flows for the years then ended, which report appears in the March 31, 1997
annual report on Form 10-K of Airways Corporation and subsidiary.



                                             KPMG PEAT MARWICK LLP




Orlando, Florida
June 6, 1997
QuickLinks
 -- Click here to rapidly navigate through this document









































 
 

  Exhibit 10.1    
    


 
    AMENDMENT NO. 1    
    
    TO THE    
    
    HALCÓN RESOURCES CORPORATION    
    
    2016 LONG-TERM INCENTIVE PLAN    
    


        This Amendment No. 1 (this "Plan Amendment") to the Halcón Resources
Corporation 2016 Long-Term Incentive Plan (the "Plan") was approved and adopted by the Board of Directors of Halcón Resources Corporation
(the "Company") on February 28, 2017, subject to approval by the Company's stockholders. On March 6, 2017, stockholders holding a majority
of the Company's outstanding voting stock, as of such date, authorized and approved this Plan Amendment by written consent. In accordance with Section 228 of the Delaware General Corporation
Law, the Company mailed a definitive information statement to all stockholders of record, which serves as notice (the "Notice") of the taking of a
corporate action without a meeting by less than unanimous written consent of the Company's stockholders. This Plan Amendment, pursuant to the rules and regulations
promulgated by the Exchange Act, to which the Company is subject, shall be effective on April 6, 2017, being on or about 20 calendar days following the Notice, as follows: 



        1.     The
first sentence of Section 1.3 of the Plan is hereby deleted in its entirety and replaced with the following: 




"Subject
to the limitations set forth herein, Awards may be made under this Plan for a total of 19,000,000 shares of the Company's Common Stock." 





        2.     Section 4.1(a)(ii) of the Plan is hereby deleted in its entirety and replaced with the following: 




"(ii)
the maximum aggregate number of shares that may be issued under the Plan through Incentive Stock Options is 19,000,000. 





        3.     Section 4.1(b) of the Plan is hereby deleted in its entirety and replaced with the following: 




"(b)
Subject to Article XII, the aggregate number of shares of Common Stock made subject to the grant of Restricted Stock Awards, Restricted Stock Unit Awards, Performance Unit Awards,
Performance Bonus Awards, Stock Awards and Other Incentive Awards to any Eligible Employee in any calendar year which are intended to constitute "performance-based compensation" within the meaning of
Section 162(m) of the Code may not exceed 19,000,000." 






        In
all other respects, the Plan remains unchanged and in full force and effect. 


        IN
WITNESS WHEREOF, this Amendment No. 1 to the Plan has been executed to be effective as of April 6, 2017. 

 


 
 


					
	 	 	HALCÓN RESOURCES CORPORATION
	

 	
 	
  By:	
 	
/s/ FLOYD C. WILSON






  Floyd C. Wilson
 Chairman of the Board, Chief Executive Officer and President




 

 








QuickLinks



Exhibit 10.1


AMENDMENT NO. 1 TO THE HALCÓN RESOURCES CORPORATION 2016 LONG-TERM INCENTIVE PLAN
§ 500.25 Anthelmintic drugs for use in animals. ( a ) The Commissioner of Food and Drugs has determined that, in order to assure that anthelmintic drugs, including animal feeds bearing or containing such drugs, which do not carry the prescription statement are labeled to provide adequate directions for their effective use, labeling of these anthelmintic drugs shall bear, in addition to other required information, a statement that a veterinarian should be consulted for assistance in the diagnosis, treatment, and control of parasitism.
( b ) The label and any labeling furnishing or purporting to furnish directions for use, shall bear conspicuously the following statement: “Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.”
( c ) For drugs covered by approved new animal drug applications, the labeling revisions required for compliance with this section may be placed into effect without prior approval, as provided for in § 514.8(c)(3) of this chapter. For drugs listed in the index, the labeling revisions required for compliance with this section may be placed into effect without prior granting of a request for a modification, as provided for in § 516.161(b)(1) of this chapter.
( d ) Labeling revisions required for compliance with this section shall be placed into effect by February 25, 1975, following which, any such drugs that are introduced into interstate commerce and not in compliance with this section will be subject to regulatory proceedings.
[40 FR 13802, Mar. 27, 1975, as amended at 71 FR 74782, Dec. 13, 2006; 72 FR 69120, Dec. 6, 2007]
#### § 510.95 [Reserved]
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

JOHN GOICOECHEA,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

No. 4D21-312

[September 30, 2021]

Appeal from the County Court for the Seventeenth Judicial Circuit, 

Broward County; Mindy F. Solomon, Judge; L.T. Case Nos. 17-002720-

MM10A and 18-000042AC10A.

Howard Finkelstein, Public Defender, and Sarah W. Sandler, Assistant 

Public Defender, Fort Lauderdale, for appellant.

Ashley B. Moody, Attorney General, Tallahassee, and Alexandra A. 

Folley, Assistant Attorney General, West Palm Beach, for appellee.

PER CURIAM.

Affirmed.

GROSS, MAY and DAMOORGIAN, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
§ 1316.46 Inspection of record. ( a ) The record bearing on any proceeding, except for material described in subsection (b) of this section, shall be available for inspection and copying by any person entitled to participate in such proceeding, during office hours in the office of the Hearing Clerk, Drug Enforcement Administration. See the Table of DEA Mailing Addresses in § 1321.01 of this chapter for the current mailing address.
( b ) The following material shall not be available for inspection as part of the record: ( 1 ) A research protocol filed with an application for registration to conduct research with controlled substances listed in Schedule I, pursuant to § 1301.32 (a)(6) of this chapter, if the applicant requests that the protocol be kept confidential;
( 2 ) An outline of a production or manufacturing process filed with an application for registration to manufacture a new narcotic controlled substance, pursuant to § 1301.33 of this chapter, if the applicant requests that the outline be kept confidential;
( 3 ) Any confidential or trade secret information disclosed in conjunction with an application for registration, or in reports filed while registered, or acquired in the course of an investigation, entitled to protection under subsection 402(a) (8) of the Act (21 U.S.C. 842(a) (8)) or any other law restricting public disclosure of information; and
( 4 ) Any material contained in any investigatory report, memorandum, or file, or case report compiled by the Administration.
[36 FR 7820, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973, as amended at 62 FR 13970, Mar. 24, 1997; 75 FR 10645, Mar. 9, 2010]
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JAN-31-2001
<PERIOD-START>                             FEB-01-2000
<PERIOD-END>                               APR-30-2000
<CASH>                                           1,722
<SECURITIES>                                         0
<RECEIVABLES>                                    1,035
<ALLOWANCES>                                       188
<INVENTORY>                                        544
<CURRENT-ASSETS>                                 3,211
<PP&E>                                           2,564
<DEPRECIATION>                                   1,373
<TOTAL-ASSETS>                                   4,460
<CURRENT-LIABILITIES>                              726
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         7,178
<OTHER-SE>                                     (3,444)
<TOTAL-LIABILITY-AND-EQUITY>                     4,460
<SALES>                                          2,178
<TOTAL-REVENUES>                                 2,178
<CGS>                                            1,196
<TOTAL-COSTS>                                    1,196
<OTHER-EXPENSES>                                   608
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    392
<INCOME-TAX>                                        10
<INCOME-CONTINUING>                                382
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       382
<EPS-BASIC>                                        .02
<EPS-DILUTED>                                      .02


</TABLE>